|
|
|
40
|
50512
|
HYDROGEN PEROXIDE 6% (FED/ATB)
|
HYDROGEN PEROXIDE
|
HYDROGEN PEROXIDE
|
150ML
|
B
|
2.58
|
0.02
|
SOLUTION
|
0
|
ML
|
FED
|
FEDERATED PHARMACEUTICAL CO. LT
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5228
|
MOUTH WASHES AND GARGLES
|
2022-05-11
|
2024-03-31
|
Change Local Agent
|
TOPICAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-05-11
|
|
|
|
40
|
50514
|
HYDROGEN PEROXIDE 6% (FED/RXP)
|
HYDROGEN PEROXIDE
|
HYDROGEN PEROXIDE
|
150ML
|
B
|
2.58
|
0.02
|
SOLUTION
|
0
|
ML
|
FED
|
FEDERATED PHARMACEUTICAL CO. LT
|
RXP
|
RX PRO INC
|
|
5228
|
MOUTH WASHES AND GARGLES
|
2022-04-01
|
2022-05-11
|
Delete from contract
|
TOPICAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-05-11
|
|
|
|
40
|
5051H
|
HYDROGEN PEROXIDE 6% (THR/SBI)
|
HYDROGEN PEROXIDE
|
HYDROGEN PEROXIDE
|
200ML
|
B
|
1.85
|
0.01
|
SOLUTION
|
0
|
ML
|
THR
|
THORNTON & ROSS LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
5228
|
MOUTH WASHES AND GARGLES
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
5051M
|
HYDROGEN PEROXIDE 6% SOLN (LDP) (B)
|
HYDROGEN PEROXIDE
|
HYDROGEN
|
250ML
|
B
|
4.87
|
0.0195
|
ML
|
0
|
BOTT
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
42
|
5051M
|
HYDROGEN PEROXIDE 6% SOLN (LDP)
|
HYDROGEN PEROXIDE
|
HYDROGEN
|
250ML
|
B
|
5.46
|
0.02
|
ML
|
0
|
BOTT
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2026-04-01
|
2028-03-31
|
|
TOPICAL
|
0
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
40
|
5062AB
|
REHYDRATION SALTS (CIP/AHI)
|
REHYDRATION SALTS
|
REHYDRATION SALTS
|
30'S
|
A
|
17.91
|
0.60
|
|
10
|
SACH
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4012
|
REPLACEMENT THERAPY
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
40
|
5062AD
|
REHYDRATION SALTS PWDR (HEA/RXP)
|
REHYDRATION SALTS
|
REHYDRATION SALTS
|
30'S
|
A
|
18.62
|
0.62
|
POWDER
|
10
|
SACH
|
HEA
|
HEALTH 2000 INC
|
RXP
|
RX PRO INC
|
|
4012
|
REPLACEMENT THERAPY
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
41
|
5062AF
|
PROLYTE ORS PWDR (CIP) REHYDRATION SALTS
|
REHYDRATION SALTS
|
PROLYTE ORS
|
40'S
|
A
|
23.92
|
0.598
|
BOX
|
10
|
SACH
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4012
|
REPLACEMENT THERAPY
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
REPLACEMENT THERAPY
|
|
|
|
|
42
|
5062AF
|
PROLYTE ORS PWDR (CIP) REHYDRATION SALTS
|
REHYDRATION SALTS
|
PROLYTE ORS
|
40'S
|
A
|
23.92
|
0.60
|
BOX
|
10
|
SACH
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4012
|
REPLACEMENT THERAPY
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
REPLACEMENT THERAPY
|
|
|
|
|
40
|
5062AJ
|
REHYDRATION SALTS (HEA/ATB)
|
GLUCOSE|POTASSIUM CHLORIDE|SODIUM CHLORIDE|SODIUM CITRATE
|
REHYDRATION SALTS
|
30'S
|
A
|
18.62
|
0.6207
|
SACHET
|
|
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
4012
|
REPLACEMENT THERAPY
|
2022-12-07
|
2024-03-31
|
Change Local Agent
|
ORAL
|
0
|
REPLACEMENT THERAPY
|
2022-11-25
|
|
|
|
41
|
5062AK
|
DEX-LITOS PWDR (LAF) REHYDRATION SALTS (C)
|
REHYDRATION SALTS
|
DEX-LITOS
|
25'S
|
C
|
31.26
|
1.2504
|
BOX
|
0
|
SACH
|
LAF
|
LABORATORIOS ALFA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4012
|
REPLACEMENT THERAPY
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
REPLACEMENT THERAPY
|
|
|
|
|
42
|
5062AK
|
DEX-LITOS PWDR (LAF) REHYDRATION SALTS
|
REHYDRATION SALTS
|
DEX-LITOS
|
25'S
|
C
|
31.26
|
1.25
|
BOX
|
10
|
SACH
|
LAF
|
LABORATORIOS ALFA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4012
|
REPLACEMENT THERAPY
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
REPLACEMENT THERAPY
|
|
|
|
|
41
|
5062AL
|
DEX-LITOS PWDR (LAF) REHYDRATION SALTS (C)
|
REHYDRATION SALTS
|
DEX-LITOS
|
50'S
|
C
|
63.88
|
1.2776
|
BOX
|
0
|
SACH
|
LAF
|
LABORATORIOS ALFA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4012
|
REPLACEMENT THERAPY
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
REPLACEMENT THERAPY
|
|
|
|
|
41
|
5062AM
|
DEX-LITOS PWDR (LAF) REHYDRATION SALTS (C)
|
REHYDRATION SALTS
|
DEX-LITOS
|
25 SACH
|
C
|
31.26
|
1.2504
|
BOX
|
0
|
SACH
|
LAF
|
LABORATORIOS ALFA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4012
|
REPLACEMENT THERAPY
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
REPLACEMENT THERAPY
|
|
|
|
|
41
|
5062AN
|
DEX-LITOS PWDR (LAF) REHYDRATION SALTS (C)
|
REHYDRATION SALTS
|
DEX-LITOS
|
50 SACH
|
C
|
63.88
|
1.2776
|
BOX
|
0
|
SACH
|
LAF
|
LABORATORIOS ALFA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4012
|
REPLACEMENT THERAPY
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
REPLACEMENT THERAPY
|
|
|
|
|
42
|
5062AN
|
DEX-LITOS PWDR (LAF) REHYDRATION SALTS
|
REHYDRATION SALTS
|
DEX-LITOS
|
50 SACH
|
C
|
63.88
|
1.28
|
BOX
|
10
|
SACH
|
LAF
|
LABORATORIOS ALFA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4012
|
REPLACEMENT THERAPY
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
REPLACEMENT THERAPY
|
|
|
|
|
41
|
5062AP
|
REHYDRATION SALTS ORANGE PWDR (MPI)
|
REHYDRATION SALTS
|
REHYDRATION SALTS ORANGE
|
100'S
|
A
|
32.57
|
0.3257
|
BOX
|
10
|
SACH
|
MPI
|
MEPRO PHARMACEUTICALS INTERNATIONAL LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4012
|
REPLACEMENT THERAPY
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
REPLACEMENT THERAPY
|
|
|
|
|
40
|
50831
|
NEBIDO 250MG/ML INJ (BSP/COL) TESTOSTERONE
|
TESTOSTERONE
|
NEBIDO
|
4ML VIAL
|
BQ
|
108.73
|
108.73
|
INJECTION
|
0
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
6808
|
ANDROGENS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
50833
|
NEBIDO 250MG/ML INJ (BSP/AHI) TESTOSTERONE
|
TESTOSTERONE
|
NEBIDO
|
4ML VIAL
|
BQ
|
108.73
|
108.73
|
INJECTION
|
0
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6808
|
ANDROGENS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
42
|
50837
|
PRIMOTESTON 250MG/ML INJ (BSP) TESTOSTER
|
TESTOSTERONE
|
PRIMOTESTON
|
250MG AMP
|
BQ
|
33.14
|
33.14
|
AMPG
|
4
|
AMP
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
AVENTA BARBADOS
|
|
6808
|
ANDROGENS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANDROGENS
|
|